Autopsy report · NCT04397679

Partial Brain RT, Temozolomide, Chloroquine, and TTF Therapy for the Treatment of Newly Diagnosed Glioblastoma

“slow accrual”

The sponsor’s own words in the registry.

Life of this trial

• Registered 1 year 3 months before it started.
• Ran for about 2 years 9 months before it stopped.
• 2 participants enrolled.
• No results are posted on the registry.

Vital statistics

Status

Terminated

Phase

Phase 1

Sponsor

Barbara Ann Karmanos Cancer Institute

Sponsor type

University, hospital or other

Conditions

Glioblastoma; Gliosarcoma

Interventions

3-Dimensional Conformal Radiation Therapy; Intensity-Modulated Radiation Therapy (IMRT); Temozolomide; Chloroquine; Tumor Treating Fields Therapy (TTF)

Participants

2

Sites

1

Countries

United States

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.